These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9178167)

  • 1. The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.
    Meininger V; Dib M; Aubin F; Jourdain G; Zeisser P
    J Neurol; 1997 May; 244 Suppl 2():S22-5. PubMed ID: 9178167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Meininger V
    Lancet; 1996 May; 347(9013):1425-31. PubMed ID: 8676624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
    J Neurosci Nurs; 1996 Aug; 28(4):275. PubMed ID: 8880606
    [No Abstract]   [Full Text] [Related]  

  • 7. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Powe L; Durrleman S; Delumeau JC; Meininger V
    Neurology; 1996 Dec; 47(6 Suppl 4):S242-50. PubMed ID: 8959996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.
    Miller RG; Bouchard JP; Duquette P; Eisen A; Gelinas D; Harati Y; Munsat TL; Powe L; Rothstein J; Salzman P; Sufit RL
    Neurology; 1996 Oct; 47(4 Suppl 2):S86-90; discussion S90-2. PubMed ID: 8858057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis?
    Mitsumoto H
    Ann Pharmacother; 1997 Jun; 31(6):779-81. PubMed ID: 9184724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole: a new agent for amyotrophic lateral sclerosis.
    Wagner ML; Landis BE
    Ann Pharmacother; 1997 Jun; 31(6):738-44. PubMed ID: 9184716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
    Fang T; Al Khleifat A; Meurgey JH; Jones A; Leigh PN; Bensimon G; Al-Chalabi A
    Lancet Neurol; 2018 May; 17(5):416-422. PubMed ID: 29525492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
    Bensimon G; Lacomblez L; Meininger V
    N Engl J Med; 1994 Mar; 330(9):585-91. PubMed ID: 8302340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L; Dib M; Doppler V; Faudet A; Robin V; Salachas F; Bensimon G; Meininger V
    Therapie; 2002; 57(1):65-71. PubMed ID: 12090150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2001; (4):CD001447. PubMed ID: 11687111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N; Shindo M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.